Managing Influenza in the High-Risk Patient

Following a PCE Symposia Live Stream Series an expert in infectious diseases and influenza gives his personal perspectives on influenza treatment and post-exposure chemoprophylaxis strategies in immunosuppressed adults and children including optimal use of neuraminidase inhibitors (NAIs) and baloxavir.

Share

Program Content

Activities

My Key Points on Outpatient Influenza Management in the Immunosuppressed Population
My Key Points on Outpatient Influenza Management in the Immunosuppressed Population
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2021

Expires: August 04, 2022

My Key Points on Outpatient Influenza Post-Exposure Chemoprophylaxis Strategies in Immunosuppressed Populations
My Key Points on Outpatient Influenza Post-Exposure Chemoprophylaxis Strategies in Immunosuppressed Populations
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2021

Expires: August 04, 2022

My Take on Influenza Treatment in the Pediatric Population
My Take on Influenza Treatment in the Pediatric Population
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2021

Expires: August 04, 2022

Faculty

cover img faculity

Paul G. Auwaerter, MD

Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Supporters

This activity is supported by an educational grant from

Genentech, a member of the Roche Group